The candidate is a combination of an mRNA therapeutic vaccine and Merck’s cancer drug Keytruda.

Source: [MarketWatch](https://www.marketwatch.com/story/modernas-stock-doubles-on-promising-cancer-vaccine-results-896b1f2c?mod=mw_rss_topstories)

Sponsored